It's an upgrade worth making, but it comes down to your privacy concerns.

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

As organizations race to adopt artificial intelligence, the conversation has increasingly shifted from raw model performance ...

Recursion harnesses AI for large-scale drug discovery, while Summit's betting on a single oncology candidate. How do their ...

Autonomous AI post-training reached frontier scale for the first time: NVIDIA researchers published a paper showing an AI ...

The frontier model is a commodity. The companies winning are the ones that own distribution, and venture capital is paying up ...

This week’s cybersecurity recap covers Firefox and Chrome bugs, EDR-killer tools, a TV botnet, an OpenBSD flaw, Android ...

A single missing feature in Bitcoin Script has spawned twelve competing proposals. Cointelegraph Research gives an overview. With the recent diversification of consensus clients into Core and Knots ...

Nvidia CEO Jensen Huang (R) and SK Group Chairman Chey Tae-won (L) hand out "HBM chip" snacks to reporters during their dinner at a Korean barbecue restaurant in Seoul on June 5, 2026. Nvidia chief ...

Building a model capable of RSI would require automating a range of specialist tasks currently carried out by humans. At present data scientists work on the theory of AI and coders put it into ...

Multiple milestones achieved or on track across wholly owned and partnered programs REC-1245 (RBM39 degrader): Early clinical data in solid tumors demonstrate a well-tolerated safety profile and ...

AI success depends on whether enterprise data is ready, reachable, and close enough to the workloads that need it. In this eSpeaks episode, Dell Technologies’ Vrashank Jain explains why fragmented ...